Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07342556 · ClinicalTrials.gov registry record · NA
Evaluating Modes of Influenza Transmission 2b Baseline SAR
A NA study, sponsored by University of Maryland, College Park.
- Not yet
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT07342556: Clinical Trial NA study, sponsored by University of Maryland, College Park.
NCT07342556 is a NA study that has not yet begun recruiting, run by University of Maryland, College Park. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07342556, a NA study, has not yet begun recruiting, sponsored by University of Maryland, College Park.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
This is a research study to investigate how influenza transmits from person-to-person. Participation as a healthy "Recipient" in this study involves: * Home semi-quarantine lasting about 14 days during which the participants must wear an N95 in class and take other precautions * Daily assessments and clinic visits for 14 days * Spending every weekday evening for about 14 days from around 6 - 10 pm, including a provided dinner, in a controlled environment. There may be additional sessions and different required participation times on weekends * Exposure to people infected with influenza in the controlled environment * Three blood draws, at the start, at the end of 14 days, and about a month after the end. * A follow-up clinic visits one month after the end of home semi-quarantine * A two-month follow-up phone call. This study may increase the participant's risk of catching influenza. If the participants get infected during the study, the investigators may: * Provide the participants with a prescription for antiviral medication or * Refer the participants for medical care * Ask the participants to become a Donor and expose other Recipients. The participants will be compensated for their time and active participation in the study; however, they may not personally benefit from the study. While the participants may receive supportive care for an infection resulting from the study, this is not meant to replace their regular medical care. If the participants become very ill and need referral for medical care, they or their medical insurance will be billed. If the participants are someone who recently became infected with influenza either through their daily activities or by participating in this study as a Recipient, they are invited to participate in this research study as a Donor and interact with a group of health participants in a controlled environment. Participation in this study as a Donor involves exposing Recipients for at least one and up to five days includ
Primary Outcome
Transmission of influenza infection defined as having \>1 nasal swab test positive for an influenza virus matching the type and subtype detected in a trial Donor.
Interventions
- OTHER Exposure to Donors with naturally acquired influenza virus infection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2026-01 |
| Est. Completion | 2026-05 |
| Phase | NA |
What is known before NCT07342556 opens enrollment
NCT07342556 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which Exposure to Donors with naturally acquired influenza virus infection is the first listed.
NCT07342556 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07342556 about?
NCT07342556 is a clinical study titled "Evaluating Modes of Influenza Transmission 2b Baseline SAR". This is a research study to investigate how influenza transmits from person-to-person. Participation as a healthy "Recipient" in this study involves: * Home semi-quarantine lasting about 14 days during which the participants must wear an N95 in class and take other precautions * Daily assessments a...
What is the current status of trial NCT07342556?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2026-01. Estimated completion is 2026-05.
What interventions are being tested in trial NCT07342556?
The interventions under investigation include: Exposure to Donors with naturally acquired influenza virus infection (OTHER).
Who is sponsoring clinical trial NCT07342556?
This trial is sponsored by University of Maryland, College Park, which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07342556's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia